Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Buy
302
+102
+51% +$104K 0.11% 93
2026
Q1
$184K Buy
200
+14
+8% +$14.2K 0.07% 108
2025
Q4
$200K Buy
186
+44
+31% +$42.1K 0.06% 106
2025
Q3
$108K Sell
142
-5
-3% -$3.72K 0.03% 135
2025
Q2
$115K Sell
147
-5
-3% -$3.88K 0.03% 126
2025
Q1
$126K Buy
152
+21
+16% +$17.5K 0.04% 120
2024
Q4
$101K Buy
+131
New +$108K 0.03% 119

Other funds holding LLY

S&T Bank's LLY Position: Q2 2026 in Review

S&T Bank increased its Eli Lilly (LLY) stake by 51% in Q2 2026, buying an estimated $104K and bringing the position to 302 shares worth $362K. The position accounts for 0.11% of the portfolio, ranked #93.

S&T Bank first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • S&T Bank held 302 shares of Eli Lilly worth $362K as of Q2 2026.
  • S&T Bank bought 102 Eli Lilly shares in Q2 2026, an estimated $104K.
  • Eli Lilly made up 0.11% of S&T Bank's portfolio in Q2 2026, its #93 holding.
  • S&T Bank first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.